GlassScriptPhysician profile
Elizabeth Camann
NPI 1851723217
$606.83
in general payments reported to CMS, 2019-2025
14 companies · $188 in 2025
The $188 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $57.20 · 2023: $269 · 2024: $92.90 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $549.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $87.93 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $75.76 | 2023-2025 | |
| Corium, LLC | $74.35 | 2023 | Azstarys |
| Baxter Healthcare | $57.20 | 2022 | |
| Organon LLC | $52.53 | 2023-2025 | Nexplanon |
| Pfizer INC. | $44.33 | 2025 | |
| Kaleo, INC. | $41.75 | 2023-2024 | Auvi-Q |
| Cranial Technologies, INC | $36.52 | 2023 | Doc Band |
| Merck Sharp & Dohme LLC | $32.29 | 2024-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Astrazeneca Pharmaceuticals LP | $24.49 | 2024 | Flumist Quadrivalent |
| Alexion Pharmaceuticals, INC. | $23.54 | 2023 | Koselugo |
| Collegium Pharmaceutical, INC. | $21.76 | 2025 | Jornay Pm |
| Ironshore Pharmaceuticals INC. | $19.57 | 2023 | Jornay Pm |
| Phadia US INC. | $14.81 | 2025 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Camann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.